# Measurement of Iohexol Plasma Clearance in Patients Leaving ICU After Acute Renal Failure

> **NCT02961478** · PHASE3 · UNKNOWN · sponsor: **University Hospital, Angers** · enrollment: 150 (estimated)

## Conditions studied

- Acute Renal Failure

## Interventions

- **DRUG:** IOHEXOL

## Key facts

- **NCT ID:** NCT02961478
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02-10
- **Primary completion:** 2020-06
- **Final completion:** 2020-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2019-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02961478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02961478, "Measurement of Iohexol Plasma Clearance in Patients Leaving ICU After Acute Renal Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02961478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*